A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer

BACKGROUND: Recently, neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil (NAC-DCF) was identified as a novel strong regimen with a high rate of pathological complete response (pCR) in advanced esophageal cancer in Japan. Predicting pCR will contribute to the therapeutic strategy and th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Fujishima, Hajime, Fumoto, Shoichi, Shibata, Tomotaka, Nishiki, Kohei, Tsukamoto, Yoshiyuki, Etoh, Tsuyoshi, Moriyama, Masatsugu, Shiraishi, Norio, Inomata, Masafumi
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685591/
https://ncbi.nlm.nih.gov/pubmed/29136005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0188098
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars